Strain-Specific Variation of the Decorin-Binding Adhesin DbpA Influences the Tissue Tropism of the Lyme Disease Spirochete

English version České info

Lyme disease, the most common vector-borne disease in the United States, is caused by a bacterium, Borrelia burgdorferi. This bacterium infects the skin at the site of the tick bite and then can spread to other tissues, such as the heart, joints or nervous system, causing carditis, arthritis or neurologic disease. To colonize human tissues, the pathogen produces surface proteins that promote bacterial attachment to these sites. For example, DbpA binds to decorin, a component of human tissue. Different Lyme disease strains differ in the particular tissues they colonize and the disease they cause, but we do not understand why. Different strains also make distinct versions of DbpA that bind decorin differently, so variation of DbpA might contribute to strain-to-strain variation in clinical manifestations. To test this, we infected mice with Lyme disease strains that were identical except for the particular DbpA variant they produced. We found that the strains colonized different tissues and caused different diseases, such as arthritis or carditis. These results provide the first solid evidence that variation of an outer surface protein, in this case DbpA, influences what tissues are most affected during Lyme disease.

Vyšlo v časopise: Strain-Specific Variation of the Decorin-Binding Adhesin DbpA Influences the Tissue Tropism of the Lyme Disease Spirochete. PLoS Pathog 10(7): e32767. doi:10.1371/journal.ppat.1004238
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1004238

Souhrn

Zdroje

1. SteereAC, CoburnJ, GlicksteinL (2004) The emergence of Lyme disease. J Clin Invest 113: 1093–1101.

2. RadolfJD, CaimanoMJ, StevensonB, HuLT (2012) Of ticks, mice and men: understanding the dual-host lifestyle of Lyme disease spirochaetes. Nat Rev Microbiol 10: 87–99.

3. KenedyMR, LenhartTR, AkinsDR (2012) The role of Borrelia burgdorferi outer surface proteins. FEMS Immunol Med Microbiol 66: 1–19.

4. SteereAC (2001) Lyme disease. N Engl J Med 345: 115–125.

5. BrissonD, DrecktrahD, EggersCH, SamuelsDS (2012) Genetics of Borrelia burgdorferi. Annu Rev Genet 46: 515–536.

6. HildenbrandP, CravenDE, JonesR, NemeskalP (2009) Lyme neuroborreliosis: manifestations of a rapidly emerging zoonosis. AJNR Am J Neuroradiol 30: 1079–1087.

7. LelovasP, DontasI, BassiakouE, XanthosT (2008) Cardiac implications of Lyme disease, diagnosis and therapeutic approach. Int J Cardiol 129: 15–21.

8. Puius YA, Kalish RA (2008) Lyme arthritis: pathogenesis, clinical presentation, and management. Infect Dis Clin North Am 22: : 289–300, vi–vii.

9. WangG, OjaimiC, WuH, SaksenbergV, IyerR, et al. (2002) Disease severity in a murine model of lyme borreliosis is associated with the genotype of the infecting Borrelia burgdorferi sensu stricto strain. J Infect Dis 186: 782–791.

10. WangG, van DamAP, SchwartzI, DankertJ (1999) Molecular typing of Borrelia burgdorferi sensu lato: taxonomic, epidemiological, and clinical implications. Clin Microbiol Rev 12: 633–653.

11. WangG, OjaimiC, IyerR, SaksenbergV, McClainSA, et al. (2001) Impact of genotypic variation of Borrelia burgdorferi sensu stricto on kinetics of dissemination and severity of disease in C3H/HeJ mice. Infect Immun 69: 4303–4312.

12. JonesKL, GlicksteinLJ, DamleN, SikandVK, McHughG, et al. (2006) Borrelia burgdorferi genetic markers and disseminated disease in patients with early Lyme disease. J Clin Microbiol 44: 4407–4413.

13. CoburnJ, BartholdSW, LeongJM (1994) Diverse Lyme disease spirochetes bind integrin alpha IIb beta 3 on human platelets. Infect Immun 62: 5559–5567.

14. Craig-MyliusKA, LeeM, JonesKL, GlicksteinLJ (2009) Arthritogenicity of Borrelia burgdorferi and Borrelia garinii: comparison of infection in mice. Am J Trop Med Hyg 80: 252–258.

15. WilskeB, Preac-MursicV, JaurisS, HofmannA, PradelI, et al. (1993) Immunological and molecular polymorphisms of OspC, an immunodominant major outer surface protein of Borrelia burgdorferi. Infect Immun 61: 2182–2191.

16. KraiczyP, SkerkaC, BradeV, ZipfelPF (2001) Further characterization of complement regulator-acquiring surface proteins of Borrelia burgdorferi. Infect Immun 69: 7800–7809.

17. RogersEA, MarconiRT (2007) Delineation of species-specific binding properties of the CspZ protein (BBH06) of Lyme disease spirochetes: evidence for new contributions to the pathogenesis of Borrelia spp. Infect Immun 75: 5272–5281.

18. LagalV, PortnoiD, FaureG, PosticD, BarantonG (2006) Borrelia burgdorferi sensu stricto invasiveness is correlated with OspC-plasminogen affinity. Microbes Infect 8: 645–652.

19. WallichR, PattathuJ, KitiratschkyV, BrennerC, ZipfelPF, et al. (2005) Identification and functional characterization of complement regulator-acquiring surface protein 1 of the Lyme disease spirochetes Borrelia afzelii and Borrelia garinii. Infect Immun 73: 2351–2359.

20. SeinostG, DykhuizenDE, DattwylerRJ, GoldeWT, DunnJJ, et al. (1999) Four clones of Borrelia burgdorferi sensu stricto cause invasive infection in humans. Infect Immun 67: 3518–3524.

21. SaloJ, LoimarantaV, LahdenneP, ViljanenMK, HytonenJ (2011) Decorin binding by DbpA and B of Borrelia garinii, Borrelia afzelii, and Borrelia burgdorferi sensu Stricto. J Infect Dis 204: 65–73.

22. PattiJM, AllenBL, McGavinMJ, HookM (1994) MSCRAMM-mediated adherence of microorganisms to host tissues. Annu Rev Microbiol 48: 585–617.

23. AntonaraS, RistowL, CoburnJ (2011) Adhesion mechanisms of Borrelia burgdorferi. Adv Exp Med Biol 715: 35–49.

24. CoburnJ, FischerJR, LeongJM (2005) Solving a sticky problem: new genetic approaches to host cell adhesion by the Lyme disease spirochete. Mol Microbiol 57: 1182–1195.

25. CoburnJ, LeongJ, ChaconasG (2013) Illuminating the roles of the Borrelia burgdorferi adhesins. Trends Microbiol 21: 372–379.

26. HagmanKE, LahdenneP, PopovaTG, PorcellaSF, AkinsDR, et al. (1998) Decorin-binding protein of Borrelia burgdorferi is encoded within a two-gene operon and is protective in the murine model of Lyme borreliosis. Infect Immun 66: 2674–2683.

27. GuoBP, BrownEL, DorwardDW, RosenbergLC, HookM (1998) Decorin-binding adhesins from Borrelia burgdorferi. Mol Microbiol 30: 711–723.

28. ParveenN, CaimanoM, RadolfJD, LeongJM (2003) Adaptation of the Lyme disease spirochaete to the mammalian host environment results in enhanced glycosaminoglycan and host cell binding. Mol Microbiol 47: 1433–1444.

29. RobertsWC, MullikinBA, LathigraR, HansonMS (1998) Molecular analysis of sequence heterogeneity among genes encoding decorin binding proteins A and B of Borrelia burgdorferi sensu lato. Infect Immun 66: 5275–5285.

30. BrownEL, WootenRM, JohnsonBJ, IozzoRV, SmithA, et al. (2001) Resistance to Lyme disease in decorin-deficient mice. J Clin Invest 107: 845–852.

31. WeeningEH, ParveenN, TrzeciakowskiJP, LeongJM, HookM, et al. (2008) Borrelia burgdorferi lacking DbpBA exhibits an early survival defect during experimental infection. Infect Immun 76: 5694–5705.

32. ShiY, XuQ, McShanK, LiangFT (2008) Both decorin-binding proteins A and B are critical for the overall virulence of Borrelia burgdorferi. Infect Immun 76: 1239–1246.

33. BlevinsJS, HagmanKE, NorgardMV (2008) Assessment of decorin-binding protein A to the infectivity of Borrelia burgdorferi in the murine models of needle and tick infection. BMC Microbiol 8: 82.

34. HydeJA, WeeningEH, ChangM, TrzeciakowskiJP, HookM, et al. (2011) Bioluminescent imaging of Borrelia burgdorferi in vivo demonstrates that the fibronectin-binding protein BBK32 is required for optimal infectivity. Mol Microbiol 82: 99–113.

35. ImaiDM, FengS, HodzicE, BartholdSW (2013) Dynamics of connective-tissue localization during chronic Borrelia burgdorferi infection. Lab Invest 93: 900–910.

36. HydeJA, TrzeciakowskiJP, SkareJT (2007) Borrelia burgdorferi alters its gene expression and antigenic profile in response to CO2 levels. J Bacteriol 189: 437–445.

37. CassattDR, PatelNK, UlbrandtND, HansonMS (1998) DbpA, but not OspA, is expressed by Borrelia burgdorferi during spirochetemia and is a target for protective antibodies. Infect Immun 66: 5379–5387.

38. OjaimiC, BrooksC, CasjensS, RosaP, EliasA, et al. (2003) Profiling of temperature-induced changes in Borrelia burgdorferi gene expression by using whole genome arrays. Infect Immun 71: 1689–1705.

39. BenoitVM, FischerJR, LinYP, ParveenN, LeongJM (2011) Allelic variation of the Lyme disease spirochete adhesin DbpA influences spirochetal binding to decorin, dermatan sulfate, and mammalian cells. Infect Immun 79: 3501–3509.

40. MorganA, WangX (2013) The Novel Heparin-Binding Motif in Decorin-Binding Protein A from Strain B31 of Borrelia burgdorferi Explains the Higher Binding Affinity. Biochemistry 52: 8237–8245.

41. BrownEL, GuoBP, O'NealP, HookM (1999) Adherence of Borrelia burgdorferi. Identification of critical lysine residues in DbpA required for decorin binding. J Biol Chem 274: 26272–26278.

42. PurserJE, LawrenzMB, CaimanoMJ, HowellJK, RadolfJD, et al. (2003) A plasmid-encoded nicotinamidase (PncA) is essential for infectivity of Borrelia burgdorferi in a mammalian host. Mol Microbiol 48: 753–764.

43. SeshuJ, Esteve-GassentMD, Labandeira-ReyM, KimJH, TrzeciakowskiJP, et al. (2006) Inactivation of the fibronectin-binding adhesin gene bbk32 significantly attenuates the infectivity potential of Borrelia burgdorferi. Mol Microbiol 59: 1591–1601.

44. ShiY, XuQ, SeemanaplliSV, McShanK, LiangFT (2008) Common and unique contributions of decorin-binding proteins A and B to the overall virulence of Borrelia burgdorferi. PLoS One 3: e3340.

45. WangX (2012) Solution structure of decorin-binding protein A from Borrelia burgdorferi. Biochemistry 51: 8353–8362.

46. LiangFT, BrownEL, WangT, IozzoRV, FikrigE (2004) Protective niche for Borrelia burgdorferi to evade humoral immunity. Am J Pathol 165: 977–985.

47. XuQ, SeemanaplliSV, McShanK, LiangFT (2007) Increasing the interaction of Borrelia burgdorferi with decorin significantly reduces the 50 percent infectious dose and severely impairs dissemination. Infect Immun 75: 4272–4281.

48. IozzoRV (1998) Matrix proteoglycans: from molecular design to cellular function. Annu Rev Biochem 67: 609–652.

49. PooleAR, RosenbergLC, ReinerA, IonescuM, BogochE, et al. (1996) Contents and distributions of the proteoglycans decorin and biglycan in normal and osteoarthritic human articular cartilage. J Orthop Res 14: 681–689.

50. ScottPG, NakanoT, DoddCM (1997) Isolation and characterization of small proteoglycans from different zones of the porcine knee meniscus. Biochim Biophys Acta 1336: 254–262.

51. BartholdSW, HodzicE, TunevS, FengS (2006) Antibody-mediated disease remission in the mouse model of lyme borreliosis. Infect Immun 74: 4817–4825.

52. McBainAL, MannDM (2001) Purification of recombinant human decorin and its subdomains. Methods Mol Biol 171: 221–229.

53. LinYP, GreenwoodA, NicholsonLK, SharmaY, McDonoughSP, et al. (2009) Fibronectin binds to and induces conformational change in a disordered region of leptospiral immunoglobulin-like protein B. J Biol Chem 284: 23547–23557.

54. LinYP, LeeDW, McDonoughSP, NicholsonLK, SharmaY, et al. (2009) Repeated domains of leptospira immunoglobulin-like proteins interact with elastin and tropoelastin. J Biol Chem 284: 19380–19391.

55. ParveenN, LeongJM (2000) Identification of a candidate glycosaminoglycan-binding adhesin of the Lyme disease spirochete Borrelia burgdorferi. Mol Microbiol 35: 1220–1234.

56. Labandeira-ReyM, SkareJT (2001) Decreased infectivity in Borrelia burgdorferi strain B31 is associated with loss of linear plasmid 25 or 28-1. Infect Immun 69: 446–455.

57. LiverisD, WangG, GiraoG, ByrneDW, NowakowskiJ, et al. (2002) Quantitative detection of Borrelia burgdorferi in 2-millimeter skin samples of erythema migrans lesions: correlation of results with clinical and laboratory findings. J Clin Microbiol 40: 1249–1253.

58. Petnicki-OcwiejaT, DeFrancescoAS, ChungE, DarcyCT, BronsonRT, et al. (2011) Nod2 suppresses Borrelia burgdorferi mediated murine Lyme arthritis and carditis through the induction of tolerance. PLoS One 6: e17414.

59. WangX, MaY, WeisJH, ZacharyJF, KirschningCJ, et al. (2005) Relative contributions of innate and acquired host responses to bacterial control and arthritis development in Lyme disease. Infect Immun 73: 657–660.

60. YangX, ColemanAS, AnguitaJ, PalU (2009) A chromosomally encoded virulence factor protects the Lyme disease pathogen against host-adaptive immunity. PLoS Pathog 5: e1000326.